endogenous glp 1 production Schematic representation of of GLP-1: Production of glp 1 signaling GLP-1-based therapies

Nordic Table offers a range of GLP-1-friendly resources, including meal plans, food lists, grocery guides, trackers, and planning tools to help you stay organized, nourish your body, and feel your best throughout your GLP-1 journey

The Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Market worth USD 2.91 billion in 2026 is growing at a CAGR of 8.24% to reach USD 4.33 billion by 2031

Researchers and leading pharma scientists now ask: could GLP-1s be our first true longevity drugs

Aims/hypothesis Regulators worldwide are reviewing safety data on glucagon-like peptide-1 receptor agonists (GLP-1RA), following reports by the Icelandic Medicines Agency in July 2023 of suicidal ideation and self-injury (SIS) in individuals taking liraglutide and semaglutide

VK-2735 is a novel dual glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide (GLP-1/GIP) receptor agonist.